| Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies K Raza, P Negi, S Takyar, A Shukla, B Amarji, OP Katare Journal of microencapsulation 28 (3), 190-199, 2011 | 71 | 2011 |
| Efficacy of novel topical liposomal formulation of cyclosporine in mild to moderate stable plaque psoriasis: a randomized clinical trial R Kumar, S Dogra, B Amarji, B Singh, S Kumar, S Sharma, K Vinay, ... JAMA dermatology 152 (7), 807-815, 2016 | 47 | 2016 |
| Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics B Amarji, NK Garg, B Singh, OP Katare Journal of drug targeting 24 (2), 147-160, 2016 | 47 | 2016 |
| Synthesis, characterization and in vitro studies of pegylated melphalan conjugates Ajazuddin, A Alexander, B Amarji, P Kanaujia Drug development and industrial pharmacy 39 (7), 1053-1062, 2013 | 42 | 2013 |
| Tamoxifen-loaded novel liposomal formulations: evaluation of anticancer activity on DMBA-TPA induced mouse skin carcinogenesis A Bhatia, B Singh, K Raza, A Shukla, B Amarji, OP Katare Journal of drug targeting 20 (6), 544-550, 2012 | 34 | 2012 |
| Lipid nano spheres (LNSs) for enhanced oral bioavailability of amphotericin B: development and characterization B Amarji, D Raghuwanshi, SP Vyas, P Kanaujia Journal of Biomedical Nanotechnology 3 (3), 264-269, 2007 | 25 | 2007 |
| Tamoxifen‐loaded liposomal topical formulation arrests hair growth in mice A Bhatia, B Singh, B Amarji, OP Katare British Journal of Dermatology 163 (2), 412-415, 2010 | 21 | 2010 |
| Fabrication of acyclovir-loaded flexible membrane vesicles (FMVs): evidence of preclinical efficacy of antiviral activity in murine model of cutaneous HSV-1 infection G Sharma, K Thakur, A Setia, B Amarji, MP Singh, K Raza, OP Katare Drug Delivery and Translational Research 7, 683-694, 2017 | 18 | 2017 |
| Package development of pharmaceutical products: Aspects of packaging materials used for pharmaceutical products B Amarji, A Kulkarni, PK Deb, R Maheshwari, RK Tekade Dosage Form Design Parameters, 521-552, 2018 | 15 | 2018 |
| Novel stain‐free lecithinized coal tar formulation for psoriasis A Bhatia, B Singh, B Amarji, P Negi, A Shukla, OP Katare International journal of dermatology 50 (10), 1246-1248, 2011 | 13 | 2011 |
| Four stages of pharmaceutical product development: preformulation, prototype development and scale-up, biological aspects, and commercialization B Amarji, SN Abed, U Bairagi, PK Deb, O Al-Attraqchi, AA Choudhury, ... Dosage Form Design Considerations, 637-668, 2018 | 10 | 2018 |
| Physicochemical aspects to be considered in pharmaceutical product development PK Deb, O Al-Attraqchi, AY Jaber, B Amarji, RK Tekade Dosage Form Design Considerations, 57-83, 2018 | 10 | 2018 |
| Sharma; Vinay, K.; Mahajan, R.; Katare, OP Efficacy of novel topical liposomal formulation of cyclosporine in mild to moderate stable plaque psoriasis: A randomized clinical trial R Kumar, S Dogra, B Amarji, B Singh, S Kumar JAMA Dermatol 152 (7), 807-815, 2016 | 7 | 2016 |
| Nano-bilosomes as potential vaccine delivery system for effective combined oral immunization against tetanus and hepatitis B A Shukla, A Bhatia, B Amarji, B Singh, OP Katare, SP Vyas Journal of biotechnology, 98-99, 2010 | 7 | 2010 |
| DEEPIKA, Rahul MAHESHWARI a Rakesh K. TEKADE. Package Development of Pharmaceutical Products B AMARJI, A KULKARNI, DEB Pran Kishore Dosage Form Design Parameters, 521-552, 2018 | 5 | 2018 |
| Pluronic F127-tailored lecithin organogel of acyclovir: Preclinical evidence of antiviral activity using BALB/c murine model of cutaneous HSV-1 infection G Sharma, B Kaur, K Thakur, A Mahajan, B Amarji, MP Singh, OP Katare Drug Delivery and Translational Research 12, 213-228, 2022 | 4 | 2022 |
| Stability and degradation studies for drug and drug product R Maheshwari, P Todke, N Soni, N Raval, PK Deb, B Amarji, ... Dosage Form Design Considerations, 225-257, 2018 | 4 | 2018 |
| R., & Tekade, RK (2018a). Chapter 15-package development of pharmaceutical products: Aspects of packaging materials used for pharmaceutical products B Amarji, A Kulkarni, PK Deb, M Deepika Dosage Form Design Parameters, 521-552, 0 | 3 | |
| Topical oleaginous compositions SK Dolai, B Amarji, PK Sasmal, NAK Ravipati, U Bairagi US Patent App. 16/531,969, 2020 | 2 | 2020 |
| Novel Liposomal Gel of an Anti-inflammatory Agent: Randomized, Double-blind Clinical Trial for Evaluation of the Efficacy and Safety in Patients with Signs and Symptoms of … S Bhatia, V Goni, S Pebam, A Taneja, N Tahasildar, SV Rajan, A Bhatia, ... The Journal of Clinical Pharmacology 50 (1090), 143, 2010 | | 2010 |
